Skip to results
Modify your search
NARROW
1-20 of 23
Authors: Lajos Pusztai
Journal Article
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations
The Oncologist, Volume 29, Issue 12, December 2024, Pages 1059–1067, https://doi.org/10.1093/oncolo/oyae259
Published: 14 October 2024
Journal Article
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay
The Oncologist, Volume 28, Issue 10, October 2023, Pages e973–e976, https://doi.org/10.1093/oncolo/oyad249
Published: 01 September 2023
Journal Article
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay
The Oncologist, Volume 28, Issue 4, April 2023, Pages 319–326, https://doi.org/10.1093/oncolo/oyad025
Published: 02 March 2023
Journal Article
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
The Oncologist, Volume 26, Issue 10, October 2021, Pages 835–844, https://doi.org/10.1002/onco.13855
Published: 23 June 2021
Journal Article
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD‐L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer
The Oncologist, Volume 25, Issue 11, November 2020, Pages 943–953, https://doi.org/10.1634/theoncologist.2020-0449
Published: 14 September 2020
Journal Article
Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy
The Oncologist, Volume 24, Issue 3, March 2019, Pages 313–318, https://doi.org/10.1634/theoncologist.2018-0213
Published: 23 August 2018
Journal Article
Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer
The Oncologist, Volume 21, Issue 9, September 2016, Pages 1063–1078, https://doi.org/10.1634/theoncologist.2015-0369
Published: 06 July 2016
Journal Article
A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice
The Oncologist, Volume 19, Issue 5, May 2014, Pages 453–458, https://doi.org/10.1634/theoncologist.2013-0377
Published: 07 April 2014
Journal Article
DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes
The Oncologist, Volume 18, Issue 10, October 2013, Pages 1063–1073, https://doi.org/10.1634/theoncologist.2013-0163
Published: 25 September 2013
Journal Article
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII‐Tubulin Expression as a Predictive Marker
The Oncologist, Volume 18, Issue 7, July 2013, Pages 787–794, https://doi.org/10.1634/theoncologist.2013-0075
Published: 12 July 2013
Journal Article
Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive Breast Cancer
The Oncologist, Volume 17, Issue 4, April 2012, Pages 492–498, https://doi.org/10.1634/theoncologist.2012-0007
Published: 14 March 2012
Journal Article
Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
The Oncologist, Volume 15, Issue 11, November 2010, Pages 1164–1168, https://doi.org/10.1634/theoncologist.2010-0059
Published: 01 November 2010
Journal Article
Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials
The Oncologist, Volume 15, Issue 5, May 2010, Pages 476–483, https://doi.org/10.1634/theoncologist.2009-0150
Published: 26 April 2010
Journal Article
Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers
The Oncologist, Volume 15, Issue 3, March 2010, Pages 246–252, https://doi.org/10.1634/theoncologist.2009-0243
Published: 12 March 2010
Journal Article
CXCR4 Expression in Early Breast Cancer and Risk of Distant Recurrence
The Oncologist, Volume 14, Issue 12, December 2009, Pages 1182–1188, https://doi.org/10.1634/theoncologist.2009-0161
Published: 25 November 2009
Journal Article
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
The Oncologist, Volume 14, Issue 4, April 2009, Pages 320–368, https://doi.org/10.1634/theoncologist.2008-0230
Published: 03 April 2009
Journal Article
Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
The Oncologist, Volume 13, Issue 8, August 2008, Page 921, https://doi.org/10.1634/theoncologist.2007-0248erratum
Published: 15 August 2008
Journal Article
Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
The Oncologist, Volume 13, Issue 5, May 2008, Pages 477–493, https://doi.org/10.1634/theoncologist.2007-0248
Published: 01 May 2008
Journal Article
Current Status of Prognostic Profiling in Breast Cancer
The Oncologist, Volume 13, Issue 4, April 2008, Pages 350–360, https://doi.org/10.1634/theoncologist.2007-0216
Published: 01 April 2008
Journal Article
Molecular Classification of Breast Cancer: Limitations and Potential
The Oncologist, Volume 11, Issue 8, September 2006, Pages 868–877, https://doi.org/10.1634/theoncologist.11-8-868
Published: 01 September 2006
